Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

NKBP

China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NKBP)

China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NKBP
DataHoraFonteTítuloCódigoCompanhia
25/07/201709:00Business WireNantKwest Announces Publication of Preclinical Data of haNK Cell Therapy in Combination with Checkpoint Inhibitor Avelumab Pr...NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
07/02/201309:52Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
07/02/201309:24Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
07/02/201307:54GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Announces Completion of MergerNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
06/02/201320:14Edgar (US Regulatory)(25-NSE)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
29/01/201312:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. to Reconvene Adjourned Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/01/201312:03Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (SC 13E3/A)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/01/201310:28Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/01/201307:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Adjourns Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
14/01/201312:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Proposes to Adjourn Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
14/12/201212:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Announces Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
25/11/201212:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Reports Third Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
05/11/201211:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. to Report Third Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
12/10/201218:00Edgar (US Regulatory)Statement of Ownership: Private Transaction (SC 13E3)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
06/10/201213:11Business WireRosen Law Firm Announces Investigation of China Nuokang Bio-Pharmaceutical In Connection With Going Private Proposal from Kin...NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
27/09/201218:15Dow Jones NewsADR Report: Shares End Higher; Resource Firms GainNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
27/09/201210:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Enters Into Definitive Agreement for Going Private TransactionNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
22/08/201217:01GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Reports Second Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
01/08/201209:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. to Report Second Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/06/201209:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Announces Change in CFONASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
08/06/201211:11Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
04/06/201209:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Appoints Lazard and Houlihan Lokey as Independent Financial Advisors to Evaluate "Going...NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
23/05/201217:01GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Reports First Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
21/05/201209:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Forms Independent Committee and Appoints Independent Legal Counsel to Evaluate "Going P...NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/05/201207:20Edgar (US Regulatory)Amended Annual and Transition Report (foreign private issuer) (20-F/A)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
10/05/201210:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. to Report First Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
09/05/201208:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Announces Receipt of "Going Private" ProposalNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
24/04/201217:33Edgar (US Regulatory)Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/03/201200:59GlobeNewswire Inc.CORRECTING and REPLACING -- China Nuokang Bio-Pharmaceutical Inc. Reports Fourth Quarter and Full Year 2011 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
14/03/201217:01GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Reports Fourth Quarter and Full Year 2011 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:NKBP

Seu Histórico Recente